Literature DB >> 19485285

Clinical factors associated with floppy iris signs: a prospective study from two centers.

Rana Altan-Yaycioglu1, Sansal Gedik, Aysel Pelit, Yonca A Akova, Ahmet Akman.   

Abstract

BACKGROUND AND
OBJECTIVE: To evaluate the relationship of intraoperative floppy iris syndrome with pseudoexfoliation, diabetes mellitus, hypertension, and alpha-1 adrenergic blocker (A1AB) use. PATIENTS AND METHODS: Five hundred patients were included in this prospective study. Intraoperative adverse events, such as pupillary constriction, iris billowing, and iris prolapse from the wound, were noted. Multinomial regression analysis was used to evaluate the relationship of intraoperative floppy iris syndrome with pseudoexfoliation, diabetes mellitus, hypertension, pupil diameter, and A1AB use.
RESULTS: Pupil constriction was significantly associated with pseudoexfoliation (P < .001). Diabetes mellitus was associated with pupil constriction and iris billowing (P = .005 and .003, respectively). Hypertension was associated with pupil constriction (P = .021). Intraoperative floppy iris syndrome was strongly associated with A1AB use and male gender (P < .001 and .039, respectively).
CONCLUSION: Intraoperative floppy iris syndrome was observed in 2.8% of patients and was strongly related to A1AB use, particularly in smaller pupil diameters. Pseudoexfoliation, diabetes mellitus, and hypertension were not associated with intraoperative floppy iris syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19485285     DOI: 10.3928/15428877-20090430-02

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  10 in total

1.  Risk factors for intraoperative floppy iris syndrome: a prospective study.

Authors:  I P Chatziralli; V Peponis; E Parikakis; A Maniatea; E Patsea; P Mitropoulos
Journal:  Eye (Lond)       Date:  2016-07-01       Impact factor: 3.775

2.  Urologic medications and ophthalmologic side effects: a review.

Authors:  Johan Gani; Nathan Perlis; Sidney B Radomski
Journal:  Can Urol Assoc J       Date:  2012-02       Impact factor: 1.862

3.  Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates.

Authors:  Anjana Haridas; Marina Syrimi; Basel Al-Ahmar; Melanie Hingorani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-02-19       Impact factor: 3.117

4.  Modified corneal incisions in intraoperative floppy iris syndrome (IFIS)-prone patients.

Authors:  Sharon Armarnik; Michael Mimouni; Eli Rosen; Ehud I Assia; Fani Segev
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-11-09       Impact factor: 3.117

5.  Floppy iris syndrome with oral imipramine: a case series.

Authors:  Arvind Gupta; Renuka Srinivasan
Journal:  Indian J Ophthalmol       Date:  2012 Mar-Apr       Impact factor: 1.848

6.  Intraoperative floppy iris syndrome in Indian population: a prospective study on incidence, risk factors, and impact on operative performance.

Authors:  Shilpa Goyal; Deepansh Dalela; Neeraj Kumar Goyal; Shobhit Chawla; Rajat Dhesi; Bela Kamboj; Abha Dalela
Journal:  Indian J Ophthalmol       Date:  2014-08       Impact factor: 1.848

Review 7.  Intraoperative Floppy Iris Syndrome: Updated Perspectives.

Authors:  Chrysanthos D Christou; Argyrios Tzamalis; Ioannis Tsinopoulos; Nikolaos Ziakas
Journal:  Clin Ophthalmol       Date:  2020-02-20

8.  Risk of intraoperative floppy iris syndrome among selective alpha-1 blockers-A consistency model of 6,488 cases.

Authors:  Ya-Hui Wang; Liang-Chen Huang; Sung Huang Laurent Tsai; Ying-Jen Chen; Chien-Liang Wu; Yi-No Kang
Journal:  Front Med (Lausanne)       Date:  2022-08-30

Review 9.  Intraoperative Floppy Iris Syndrome Induced by Tamsulosin: The Risk and Preventive Strategies.

Authors:  Mansour Tobaiqy; Waseem Aalam; David Banji; Ekram N Abd Al Haleem
Journal:  Middle East Afr J Ophthalmol       Date:  2021-04-30

10.  Intraoperative floppy iris syndrome (IFIS): what complication rates can we expect?

Authors:  Andrzej Grzybowski; Patrycja Krzyżanowska-Berkowska
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-11-27       Impact factor: 3.117

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.